{
    "paper_id": "PMC7132384",
    "metadata": {
        "title": "The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study",
        "authors": [
            {
                "first": "Tung",
                "middle": [
                    "Wai"
                ],
                "last": "Auyeung",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Jenny",
                "middle": [
                    "S.W."
                ],
                "last": "Lee",
                "suffix": "",
                "email": "jleesw_2000@yahoo.com",
                "affiliation": {}
            },
            {
                "first": "Wing",
                "middle": [
                    "Kin"
                ],
                "last": "Lai",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Chun",
                "middle": [
                    "Hung"
                ],
                "last": "Choi",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Hoi",
                "middle": [
                    "Kan"
                ],
                "last": "Lee",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Joo",
                "middle": [
                    "Shim"
                ],
                "last": "Lee",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Po",
                "middle": [
                    "Chun"
                ],
                "last": "Li",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Ka",
                "middle": [
                    "Ho"
                ],
                "last": "Lok",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yuk",
                "middle": [
                    "Yung"
                ],
                "last": "Ng",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Wai",
                "middle": [
                    "Ming"
                ],
                "last": "Wong",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yiu",
                "middle": [
                    "Ming"
                ],
                "last": "Yeung",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Hong Kong was hampered by the severe acute respiratory syndrome (SARS) epidemic from early March to June 2003. In total there were 1775 SARS cases and 299 deaths. Our hospital is a regional hospital serving a population of 1 million in the northwestern part of Hong Kong.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Treatment during the epidemic had been empirical. While corticosteroid had been the mainstay of treatment of SARS in Hong Kong,1, 2, 3, 4, 5 it was not a routine treatment elsewhere.6, 7, 8 The use of corticosteroid in the treatment of SARS has since become controversial. Some had been sceptical about its therapeutic value, especially in higher dosages, which carry immediate and long-term side effects. We performed a retrospective cohort study on the effect of corticosteroid in a group of SARS patients admitted between March and May 2003.",
            "cite_spans": [
                {
                    "start": 127,
                    "end": 128,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 130,
                    "end": 131,
                    "mention": "2",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 133,
                    "end": 134,
                    "mention": "3",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 136,
                    "end": 137,
                    "mention": "4",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 139,
                    "end": 140,
                    "mention": "5",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 182,
                    "end": 183,
                    "mention": "6",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 185,
                    "end": 186,
                    "mention": "7",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 188,
                    "end": 189,
                    "mention": "8",
                    "ref_id": "BIBREF8"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Eighty consecutive adult patients fulfilling the WHO criteria of SARS admitted between March and May 2003 were studied. Demographic characteristics, modes of exposure, clinical features, chest imaging results, biochemical, haematological and serology test results, corticosteroid treatment options, and their clinical outcomes were recorded.",
            "cite_spans": [],
            "section": "Patients",
            "ref_spans": []
        },
        {
            "text": "The adverse outcome group and the uncomplicated group were compared in terms of age, sex, laboratory results, and clinical outcomes by univariate analysis. The corticosteroid therapy group was compared with the non-corticosteroid therapy group in terms of their demographic characteristics, presence of comorbidities, peak LDH (lactate dehydrogenase) levels and adverse clinical outcomes by univariate analysis. Mann\u2013Whitney U test, Chi-Square test and Fisher-Exact test were used as appropriate.",
            "cite_spans": [],
            "section": "Statistical method ::: Methods",
            "ref_spans": []
        },
        {
            "text": "The established adverse prognostic factors for SARS mortality including old age, presence of comorbidities and high LDH levels1, 3, 6, 8, 9 were used as covariates in multiple logistic regressions to adjust for their confounding effect on adverse outcomes. All tests were two-tailed. p values less than 0.05 were taken as significant.",
            "cite_spans": [
                {
                    "start": 126,
                    "end": 127,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 129,
                    "end": 130,
                    "mention": "3",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 132,
                    "end": 133,
                    "mention": "6",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 135,
                    "end": 136,
                    "mention": "8",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 138,
                    "end": 139,
                    "mention": "9",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Statistical method ::: Methods",
            "ref_spans": []
        },
        {
            "text": "There were 33 males (42.3%) and 45 females (57.7%). The mean age was 47.7\u00b119.9 years (range 18\u201395) (Table 1\n). Nineteen patients (24.4%) were healthcare workers. Thirty-seven patients (47.4%) contracted the disease in the hospital, 30 (38.5%) in the community and 11 (14.1%) through household contact.",
            "cite_spans": [],
            "section": "Demographic characteristics ::: Results",
            "ref_spans": [
                {
                    "start": 100,
                    "end": 107,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Fever was the commonest presenting symptom (98.7%), followed by cough (53.8%), chills or rigor (42.3%), myalgia (25.6%), diarrhoea (14.1%) and headache (11.5%). On presentation, 61 patients (78.2%) were lymphopenic (lymphocyte count <1.2\u00d7109\n cells/l) and 22 (28.2%) thrombocytopenic (platelets count <153\u00d7109cells/l). Thirty-four patients (43.6%) were hyponatraemic (Na<140 mmol/l) and 22 (28.2%) were hypokalaemic (<3.0 mmol/l) (Table 1).",
            "cite_spans": [],
            "section": "Clinical features ::: Results",
            "ref_spans": [
                {
                    "start": 431,
                    "end": 438,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Thirty-one patients (39.7%) were saliva RT-PCR positive, 24 (30.8%) stool RT-PCR positive, 14 (17.9%) upper respiratory tract secretion RT-PCR positive and 3 (3.8%) urine RT-PCR positive. In total, 55 patients (70.5%) were positive for one or more RT-PCR tests. Forty patients (51.3%) had more than fourfold rise of SARS-CoV antibody titre in the convalescence phase.",
            "cite_spans": [],
            "section": "Laboratory confirmation ::: Results",
            "ref_spans": []
        },
        {
            "text": "Sixty-six patients (84.6%) received corticosteroid of various dosages. Twelve patients (15.4%) were not given any corticosteroid. Seventy-four patients (94.9%) were treated with ribavarin and 22 patients (28.2%) received lopinavir/ritonavir as antiviral therapy.",
            "cite_spans": [],
            "section": "Corticosteroid treatment ::: Results",
            "ref_spans": []
        },
        {
            "text": "Twenty-one (26.9%) of our patients died and 16 (20.5%) were admitted to the ICU. Patients with adverse outcomes were older, had more comorbidities, and were more likely to be hypokalaemic on presentation. Their trough lymphocyte count was lower, their peak neutrophil count and LDH level were higher (Table 2\n).",
            "cite_spans": [],
            "section": "Outcomes ::: Results",
            "ref_spans": [
                {
                    "start": 301,
                    "end": 308,
                    "mention": "Table 2",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "When patients were categorized according to whether corticosteroid treatment was given, and compared in terms of age, presence of comorbidities, peak LDH level and outcomes, the corticosteroid group was found to be younger and had less comorbidity. The peak LDH level, reflecting disease severity, was similar in both groups. The corticosteroid group however had more adverse outcomes (37.9 vs. 16.7%), although it did not reach statistical significance (Table 3\n).",
            "cite_spans": [],
            "section": "Comparison of patients with and without corticosteroid treatment ::: Results",
            "ref_spans": [
                {
                    "start": 455,
                    "end": 462,
                    "mention": "Table 3",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "Multivariate analysis was performed to adjust for the confounding effect of age and disease severity. Patients who were treated with corticosteroid were found to have a 20.7-fold increased risk of either ICU admission or mortality, independent of their age and disease severity as represented by peak LDH level (Table 4\n).",
            "cite_spans": [],
            "section": "Comparison of patients with and without corticosteroid treatment ::: Results",
            "ref_spans": [
                {
                    "start": 312,
                    "end": 319,
                    "mention": "Table 4",
                    "ref_id": "TABREF3"
                }
            ]
        },
        {
            "text": "Corticosteroid has been used extensively in the treatment of SARS in Hong Kong. The theoretical rational is the similarity of the radiological and histological features between bronchiolitis obliterans organising pneumonia (BOOP) and SARS pneumonia. Since corticosteroid has been shown to be effective against BOOP, it was postulated that it could be useful in reducing the complication of adult respiratory distress syndrome (ARDS) in SARS.",
            "cite_spans": [],
            "section": "Discussion",
            "ref_spans": []
        },
        {
            "text": "Our series had a high mortality rate (26.9%). The adverse prognostic factors were similar to those in other reports, namely advanced age, presence of comorbidities and high peak LDH level.1, 3, 6, 8, 9 Despite more favourable baseline characteristics (younger with less comorbidities) and similar peak LDH levels, the corticosteroid group had more adverse outcomes (37.9% vs. 16.7%), though it did not reach statistical significance. The adverse effect of corticosteroid therapy might have been masked by the younger age and better pre-morbid condition of the corticosteroid therapy group. We have therefore tried to eliminate this confounding effect by multivariate adjustment. Corticosteroid usage had then turned out to be a statistically significant independent adverse factor and was associated with more than 20-fold risk of unfavourable outcomes.",
            "cite_spans": [
                {
                    "start": 188,
                    "end": 189,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 191,
                    "end": 192,
                    "mention": "3",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 194,
                    "end": 195,
                    "mention": "6",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 197,
                    "end": 198,
                    "mention": "8",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 200,
                    "end": 201,
                    "mention": "9",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Discussion",
            "ref_spans": []
        },
        {
            "text": "Our series is relatively small. The results could have been biased by many unknown confounding factors. Only advanced age and high peak LDH level were chosen as the two important prognostic factors to make adjustment for.",
            "cite_spans": [],
            "section": "Discussion",
            "ref_spans": []
        },
        {
            "text": "Due to the limited number of cases, we did not stratify the outcomes according to different corticosteroid regimen and the timing of corticosteroid commencement. However, we recognize that therapeutic effects may vary with different dosages and may be affected by the timing of treatment.10 Some clinicians believe that the first phase of the illness is viral replication and antiviral therapy should be the mainstay of treatment, while immunemodulation therapy such as corticosteroid should be withheld until the second week to counteract the BOOP-like phase.",
            "cite_spans": [
                {
                    "start": 288,
                    "end": 290,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "Discussion",
            "ref_spans": []
        },
        {
            "text": "Corticosteroid therapy was associated with a 20-fold increase in adverse outcomes in our series. Large-scale randomized controlled trials are needed to look at the effectiveness, as well as the appropriate dosages and timing of corticosteroid treatment in SARS. Until then, clinicians should remain cautious in the use of corticosteroid in this novel disease.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: Characteristics of all, probable SARS and laboratory confirmed SARS patients\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 2: Adverse prognostic factors associated with either ICU admission or mortality\n",
            "type": "table"
        },
        "TABREF2": {
            "text": "Table 3: Comparison of characteristics, adverse prognostic factors and outcome between corticosteroid therapy group and non-corticosteroid therapy group\n",
            "type": "table"
        },
        "TABREF3": {
            "text": "Table 4: Adverse prognostic factors associated with either ICU admission or mortality by multivariate analysis\n",
            "type": "table"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "A major outbreak of severe acute respiratory syndrome in Hong Kong",
            "authors": [
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "N Engl J Med",
            "volume": "348",
            "issn": "",
            "pages": "1986-1994",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "J.C.",
                    "middle": [],
                    "last": "Ho",
                    "suffix": ""
                },
                {
                    "first": "G.C.",
                    "middle": [],
                    "last": "Ooi",
                    "suffix": ""
                },
                {
                    "first": "T.Y.",
                    "middle": [],
                    "last": "Mok",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Am J Respir Crit Care Med",
            "volume": "168",
            "issn": "",
            "pages": "1449-1456",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Severe acute respiratory syndrome (SARS): epidemiology, diagnosis and management",
            "authors": [
                {
                    "first": "G.W.K.",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "D.S.C.",
                    "middle": [],
                    "last": "Hui",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Thorax",
            "volume": "58",
            "issn": "",
            "pages": "558-560",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Severe acute respiratory syndrome: clinical outcome and prognostic correlates",
            "authors": [
                {
                    "first": "P.T.",
                    "middle": [],
                    "last": "Tsui",
                    "suffix": ""
                },
                {
                    "first": "M.L.",
                    "middle": [],
                    "last": "Kwok",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Yuen",
                    "suffix": ""
                },
                {
                    "first": "S.T.",
                    "middle": [],
                    "last": "Lai",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Emerg Infect Dis",
            "volume": "9",
            "issn": "",
            "pages": "1064-1069",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Coronavirus as a possible cause of severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "J.S.M.",
                    "middle": [],
                    "last": "Peiris",
                    "suffix": ""
                },
                {
                    "first": "S.T.",
                    "middle": [],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "L.L.M.",
                    "middle": [],
                    "last": "Poon",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Lancet",
            "volume": "361",
            "issn": "",
            "pages": "1319-1325",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Development of a standard treatment protocol for severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "L.K.",
                    "middle": [],
                    "last": "So",
                    "suffix": ""
                },
                {
                    "first": "A.C.",
                    "middle": [],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "L.Y.",
                    "middle": [],
                    "last": "Yam",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Lancet",
            "volume": "361",
            "issn": "",
            "pages": "1615-1617",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "SARS: epidemiology, clinical presentation, management, and infection control measures",
            "authors": [
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Sampathkumar",
                    "suffix": ""
                },
                {
                    "first": "Z.",
                    "middle": [],
                    "last": "Temesgen",
                    "suffix": ""
                },
                {
                    "first": "T.F.",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "R.L.",
                    "middle": [],
                    "last": "Thompson",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Mayo Clin Proc",
            "volume": "78",
            "issn": "",
            "pages": "882-890",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Clinical course and management of SARS in health care workers in Toronto: a case series",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Avendano",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Derkach",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Swan",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "CMAJ",
            "volume": "168",
            "issn": "",
            "pages": "1649-1660",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area",
            "authors": [
                {
                    "first": "C.M.",
                    "middle": [],
                    "last": "Booth",
                    "suffix": ""
                },
                {
                    "first": "L.M.",
                    "middle": [],
                    "last": "Matukas",
                    "suffix": ""
                },
                {
                    "first": "G.A.",
                    "middle": [],
                    "last": "Tomlinson",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "JAMA",
            "volume": "289",
            "issn": "",
            "pages": "2801-2809",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong",
            "authors": [
                {
                    "first": "K.W.",
                    "middle": [],
                    "last": "Choi",
                    "suffix": ""
                },
                {
                    "first": "T.N.",
                    "middle": [],
                    "last": "Chau",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Tsang",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Ann Intern Med",
            "volume": "139",
            "issn": "",
            "pages": "715-724",
            "other_ids": {
                "DOI": []
            }
        }
    }
}